Evaluation of new 99mTc-labeled HYNIC-bombesin analogue for prostate cancer imaging
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Radioanalytical and Nuclear Chemistry"
DOI: 10.1007/s10967-018-5819-z
Abstract: In this study, we introduce a new 99mTc-radiolabeled bombesin derivative for imaging of prostate cancer (PC). We used 6-hydrazinonicotinamide (HYNIC) as bi-functional chelating agent and tricine/ethylenediamine diacetic acid (EDDA) as an exchange co-ligands. Radiolabeling was achieved… read more here.
Keywords: bombesin; evaluation new; new 99mtc; prostate cancer ... See more keywords